Doha, Qatar: Qatar Precision Health Institute (QPHI) has joined Sidra Medicine as a strategic partner and co-organiser of the Precision Medicine and the Future of Genomics (PMFG) Summit 2026 for the second consecutive year. The partnership aims to strengthen scientific collaboration and advance precision health research and implementation in Qatar and internationally.
The two Qatar Foundation entities will work together on the summit’s scientific direction, combining QPHI’s expertise in population-scale genomics and multi-omics research with Sidra Medicine’s clinical and translational research capabilities.
Scheduled for 7–9 December 2026 at the Qatar National Convention Centre in Doha, the 12th edition of the summit will bring together healthcare professionals, researchers, geneticists, policymakers, regulators and industry representatives.
Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine and Executive Chair of PMFG 2026 said: “Having QPHI as a strategic partner and co-organizer reflects the strength of a partnership that continues to shape the evolution of the PMFG Summit. Our organizations share a commitment to translating genomic discoveries into meaningful healthcare impact. QPHI’s population-scale and multi-omics expertise complements Sidra Medicine’s clinical and translational strengths, bringing together the full journey from discovery to personalized and preventive care.”
Click here to join our WhatsApp channel here
The programme will explore four key areas: patient advocacy and next-generation therapeutics; global reference genomes and genomic representation across the Global South; artificial intelligence and digital medicine regulation; and scaling genomic medicine through biobanks, national programmes and paediatric care.
Dr. Emmanouil Dermitzakis, President, Qatar Precision Health Institute and Chair of the PMFG Summit 2026 Leadership Committee, said: “Precision health in Qatar has made remarkable progress, built on a coordinated national strategy that QPHI is proud to lead, with Sidra Medicine as a key clinical partner. PMFG allows us to share that journey and learn from colleagues worldwide, because in a field evolving this quickly, the open exchange of ideas is how we all move forward.”
Dr. Ammira Akil, Principal Investigator and Director of Metabolic and Mendelian Translational Program at Sidra Medicine and Managing Chair of PMFG Summit 2026 said: “As PMFG marks its 12th edition, I am proud that QPHI joins us as strategic partner and co-organizer for the second year running. This continuity matters: it allows us to build on what we started together and to design a program that connects scientific discovery with implementation and patient care. This year we have also made a deliberate effort to bring voices from across the Global South to the stage, because precision medicine can only be equitable if every population is represented in the science. QPHI’s expertise across genomics, data science and precision health has been integral to shaping that vision”.
Organisers aim to encourage international knowledge exchange and strengthen collaboration across research, clinical practice and population health. The discussions will focus on translating advances in genomics, AI and precision medicine into practical applications that can improve patient care and public health.
